Results of 2025 Annual Shareholder Meeting

04/08/2025 08:30 NZST, GENERAL

3 August 2025

Results of 2025 Annual Shareholder Meeting

At AFT Pharmaceuticals Limited’s (NZX: AFT / ASX: AFP) annual shareholder meeting held at the Milford Cruising Club, 24 Craig Road, Milford, Auckland, New Zealand today, shareholders were asked to vote on four resolutions, all of which were supported by the Board.

As required by NZX Listing Rule 6.1, all voting was conducted by a poll.

The resolutions passed by shareholders were:

1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2026 financial year.

2. That Hartley Atkinson be re-elected as a director of AFT Pharmaceuticals Limited.

3. That Allison Yorston be elected as a director of AFT Pharmaceuticals Limited.

Detail of the total number of votes cast in person or by a proxy holder are:

Resolution For Against Abstain

1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2025 financial year.

91,547,849

99.97%

26,328

0.03%

8,684

2. That Hartley Atkinson be re-elected as a director of AFT Pharmaceuticals Limited.

91,555,813

99.97% 23,395

0.03% 3,653

3. That Allison Yorston be elected as a director of AFT Pharmaceuticals Limited.

91,533,592

99.95% 42,364

0.05% 6,905

Authority for this announcement

Name of person authorised to make this announcement Malcolm Tubby, Chief Financial Officer

Contact person for this announcement Malcolm Tubby

Contact phone number +64 9 488 0232

Contact email address Investor.relations@aftpharm.com

Date of release through MAP 3 August 2025